PLAGL2 and cancer: Combining the above two results, systematic mRNA expression analysis with the Timer and GENT2 databases have shown that PLAGL2 was consistently upregulated across a wide range of cancer types that included breast, cervix, colon, esophagus, liver, lung, and brain.